According to a study published Online First in The Lancet, younger individuals who suffer with diffuse large B-cell lymphoma who received a more intensive chemotherapy regimen in conjunction with rituximab survive considerably longer, and are around two times as likely to remain in remission 3 years later, in comparison to those who receive standard chemotherapy combined with rituximab...
'Healthy For The Holidays' 10 Tips For Cancer Survivors
11/24/2011
Surviving the holidays with one's waistline, bank account and sanity intact can be challenging for everyone, but the season affords specific pitfalls and opportunities for cancer survivors who are mindful of staying healthy throughout the season and beyond. One in 20 adults in the U.S...
Study Identifies Possible Therapy For Radiation Sickness
11/24/2011
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston...
Math May Guide Future Prostate Cancer Treatments
11/24/2011
Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors...
Novel Role Identified For PEA-15 Protein In Cancer Growth
11/24/2011
A new study from the University of Hawaii Cancer Center reveals that PEA-15, a protein previously shown to slow ovarian tumor growth and metastasis, can alternatively enhance tumor formation in kidney cells carrying a mutation in a cancer-promoting gene called H-Ras...
Clues To Immunity, Wound Healing And Tumor Biology Provided By Hydrogen Peroxide
11/24/2011
Hydrogen peroxide isn't just that bottled colorless liquid in the back of the medicine cabinet that's used occasionally for cleaning scraped knees and cut fingers. It's also a natural chemical in the body that rallies at wound sites, jump-starting immune cells into a series of events...
Medications' Adverse Events - Nearly 100,000 Elderly Americans Hospitalized Annually
11/23/2011
In the U.S. each year almost 100,000 people above the age of 65 years are admitted to hospital because of emergencies caused by adverse drug events...
Is A Mole Benign Or Cancerous? New Staining Test Can Provide New Measure
11/23/2011
Up till now, finding out if a mole is a potentially life-threatening melanoma has been a complex task, resulting in both under- and over diagnosis. However, a novel diagnostic staining test has been designed, developed and studied by investigators at Weill Medical College...
Recurrent Glioblastoma - Tumor Treating Fields Versus Best Standard Chemotherapy, A Comparison
11/23/2011
On November 20, Novocure announced that long-term follow-up results from the Phase III EF-11 investigation that focused on overall survival in individuals who suffer with recurrent glioblastoma multiforme (GBM), were presented by Dr. Eric T. Wong, Co-Director, Brain Tumor Center, Beth Israel Deaconess Medical Center in Boston...
Precancerous Skin Lesions - Advantages Of Laser Removal
11/23/2011
According to a study in the November/December issue of the Archives of Facial Plastic Surgery, one of the JAMA/Archives journals, carbon dioxide laser ablation (removal) may provide an alternative treatment for lentigo maligna, a common pre-cancerous skin lesion, when radiation treatment or surgery is not possible...